Dawei Chen

This inventor holds 70 USPTO granted patents and 17 published patent applications, plus 1 CIPO patent and 16 EPO patents, primarily in Pharmaceutical Compounds (CPC class C07D). Top assignee: Achillion Pharmaceuticals, Inc.. Active years: 2006-2025.

USPTO Granted Patents = 70 (Patent Applications = 17)

% Patents Active = 72.9

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 16 (Patent Applications = 23)

Average Co-Inventor Count = 9.3

ph-index = 21

Forward Citations = 942(Granted Patents)

Forward Citations (Not Self Cited) = 275(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Middletown, CT (US) (2006 - 2018)
Guilford, CT (US) (2017 - 2024)

Company Filing History:

70 out of 104

Achillion Pharmaceuticals, Inc.

patents

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

Aryl Compounds

Heteroaryl Compounds

Heterocyclic Compounds

Macrocyclic Compounds

Immune Disorders

Inflammatory Disorders

Medical Disorders

Complement Mediated Disorders

Amino Compounds

Amide Compounds

Pharmaceutical Innovation

Guilford CT

70 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12338230 - Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders (2025-06-24),

2. 12297205 - Macrocyclic compounds for treatment of medical disorders (2025-05-13),

3. 12162860 - Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders (2024-12-10),

4. 12139497 - Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders (2024-11-12),

5. 12065459 - Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders (2024-08-20),

6. 12006307 - Pharmaceutical compounds for treatment of medical disorders (2024-06-11),

7. 11926617 - Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders (2024-03-12),

8. 11718626 - Macrocyclic compounds for treatment of medical disorders (2023-08-08),

9. 11708351 - Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders (2023-07-25),

10. 11649229 - Amide compounds for treatment of immune and inflammatory disorders (2023-05-16),

11. 11649223 - Amino compounds for treatment of immune and inflammatory disorders (2023-05-16),

12. 11447465 - Pharmaceutical compounds for treatment of medical disorders (2022-09-20),

13. 11407738 - Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders (2022-08-09),

14. 11084800 - Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders (2021-08-10),

15. 11053253 - Macrocyclic compounds for treatment of medical disorders (2021-07-06),

Title: The Innovative Mind of Dawei Chen

Introduction: Dawei Chen, a brilliant inventor hailing from Guilford, CT (US), is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Dawei Chen's latest patents include a cutting-edge smart home device that revolutionizes the way we interact with our living spaces, and a sustainable energy solution that has the potential to transform the renewable energy sector.

Career Highlights: With a career spanning over two decades, Dawei Chen has established himself as a visionary in the tech industry. His work has not only garnered critical acclaim but has also significantly impacted the lives of people around the world.

Collaborations: Throughout his career, Dawei Chen has collaborated with leading tech companies, research institutions, and universities to bring his innovative ideas to life. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Dawei Chen's relentless pursuit of innovation and his passion for pushing the boundaries of what is possible have solidified his position as a trailblazer in the world of technology. Guilford, CT (US) can proudly claim him as one of its most esteemed inventors.